S Y Tse
Chief Executive Officer bei SINO BIOPHARMACEUTICAL LIMITED
Vermögen: 1 565 Mio $ am 31.03.2024
Profil
S Y Tse ist Mitglied des Vorstands von Sino Biopharmaceutical Ltd. S Y Tse erwarb einen Bachelor-Abschluss an der Wharton School der University of Pennsylvania und einen Master-Abschluss am Schwarzman College.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
19.04.2024 | 4 055 000 000 ( 21,57% ) | 1 565 Mio $ | 31.03.2024 |
Aktive Positionen von S Y Tse
Unternehmen | Position | Beginn |
---|---|---|
SINO BIOPHARMACEUTICAL LIMITED | Chief Executive Officer | 28.07.2022 |
Chengdu Quanyuantang Pharmacy Chain Joint Stock Co., Ltd.
Chengdu Quanyuantang Pharmacy Chain Joint Stock Co., Ltd. Pharmaceuticals: MajorHealth Technology Chengdu Quanyuantang Pharmacy Chain Joint Stock Co., Ltd. is an omni-channel smart retail pharmacy. It operates both offline and online retail pharmacies. It sells and delivers pharmaceutical products through its O2O and B2C platforms. It is also involved in the wholesale of pharmaceutical products to other industry customers. The company was founded by Can Li and Zhou Hua Chen on September 12, 2012 and is headquartered in Chengdu, China. | Director/Board Member | 10.11.2020 |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd. is an innovative pharmaceutical group enterprise based in Lianyungang, China. Chia Tai Tianqing has six major product groups, including liver disease, anti-tumor, respiratory, infection, endocrine, and cardiovascular and cerebrovascular. The Chinese company invests heavily in innovative drug research and has high-level R & D platforms such as the national enterprise technology center. Chia Tai Tianqing is preparing for a number of products to enter the international market and actively undertakes corporate social responsibilities. The private company was founded in 1969, and the CEO is Kang Xin Yu. | Chairman | 30.07.2020 |
Ehemalige bekannte Positionen von S Y Tse
Unternehmen | Position | Ende |
---|---|---|
Liepin North America, Inc. | Chief Executive Officer | - |
Ausbildung von S Y Tse
The Wharton School of the University of Pennsylvania | Undergraduate Degree |
Schwarzman College | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SINO BIOPHARMACEUTICAL LIMITED | Health Technology |
Private Unternehmen | 3 |
---|---|
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd. is an innovative pharmaceutical group enterprise based in Lianyungang, China. Chia Tai Tianqing has six major product groups, including liver disease, anti-tumor, respiratory, infection, endocrine, and cardiovascular and cerebrovascular. The Chinese company invests heavily in innovative drug research and has high-level R & D platforms such as the national enterprise technology center. Chia Tai Tianqing is preparing for a number of products to enter the international market and actively undertakes corporate social responsibilities. The private company was founded in 1969, and the CEO is Kang Xin Yu. | Health Technology |
Chengdu Quanyuantang Pharmacy Chain Joint Stock Co., Ltd.
Chengdu Quanyuantang Pharmacy Chain Joint Stock Co., Ltd. Pharmaceuticals: MajorHealth Technology Chengdu Quanyuantang Pharmacy Chain Joint Stock Co., Ltd. is an omni-channel smart retail pharmacy. It operates both offline and online retail pharmacies. It sells and delivers pharmaceutical products through its O2O and B2C platforms. It is also involved in the wholesale of pharmaceutical products to other industry customers. The company was founded by Can Li and Zhou Hua Chen on September 12, 2012 and is headquartered in Chengdu, China. | Health Technology |
Liepin North America, Inc. |